Nuheara: Receives ethics approval to begin clinical trials

Nuheara Receives ethics approval to begin clinical trials

  • Nuheara (NUH) has received ethics approval from the Australian Hearing Human Research Ethics Committee (AHHREC) to commence its medical device clinical trial
  • The company has been working to develop multi-functional, personalised, intelligent hearing devices that augment a person’s hearing
  • The company said this supports its planned expansion into clinically tested and regulatory approved medical devices
  • The company Co-founder, Managing Director and CEO Justin Miller said National Acoustics Laboratories has now commenced recruiting for company’s medical device clinical trial
  • Recruitment has already begun for the trial, which the company says supports its planned expansion into clinically tested and regulatory approved medical devices
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Goldman Sachs Boosts Compliance with Anthropic’s AI Agents

The investment bank partners with Anthropic to enhance accuracy in accounting.Highlights: Goldman Sachs collaborates with Anthropic for AI-driven...

Boerse Stuttgart Merges Crypto Unit with Tradias, Strengthening Market Presence

This strategic merger aims to enhance cryptocurrency trading capabilities.Highlights: Boerse Stuttgart merges its crypto unit with Tradias.The merger...

Bank of Ireland Reduces Fraud Losses by $97 Million Using AI Technology

Advanced AI systems help detect fraudulent card transactions effectively.Highlights: Bank of Ireland saved $97 million by preventing fraud...

SoftBank’s PayPay Accelerates US IPO Filing Process

Japan's popular payment platform PayPay prepares for its initial public offering.Highlights: PayPay files for an initial public offering...